Ritonavir Supplier-Buyer Network — Trade Flow Analysis

Name: Ritonavir Supplier-Buyer Trade Network Dataset — 84+ Indian Exporters, 18+ Importers, 155+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Ritonavir supplier network, Ritonavir buyers, pharmaceutical export India, Ritonavir trade data

TransData Nexus

Ritonavir

India Pharmaceutical Trade Intelligence

$340.6M84 Suppliers155 CountriesHS 30049099

ExportsIndia → BELGIUM51.5%India → INDONESIA7.8%

ImportsUNITED STATES → India$92.3K BRAZIL → India$80.0K

#1 Supplier: HETERO LABS

Who Supplies Ritonavir? Top Manufacturers & Buyers 2026 — HETERO LABS LIMITED Leads | TransData Nexus | TransData Nexus

1HETERO LABS LIMITED

HETERO LABS LIMITED is the first-largest Ritonavir exporter from India, with a market share of 16.8% and a total export value of $57.2M across 494 shipments. Their average shipment value of $115.8K is below the market average of $219.0K, reflecting a high-volume, competitive pricing strategy.

HETERO LABS LIMITED serves 5 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 62.8% of this supplier's tracked business. Top customers include:

• TO THE ORDER OF — $35.9M across 310 shipments (62.8% of this supplier's total exports)

• M S TO THE ORDER OF ESSERS LSP I — $8.5M across 74 shipments (14.9% of this supplier's total exports)

• M/S — $6.5M across 56 shipments (11.3% of this supplier's total exports)

• EXPEDITORS INTERNATIONAL NV — $3.8M across 33 shipments (6.7% of this supplier's total exports)

• NA — $2.4M across 21 shipments (4.2% of this supplier's total exports)

Key Insight: HETERO LABS LIMITED operates with high shipment frequency (494 shipments) at a per-shipment value of $115.8K, indicating a broad distribution network with many smaller, regular orders.

2MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the second-largest Ritonavir exporter from India, with a market share of 14.8% and a total export value of $50.3M across 550 shipments. Their average shipment value of $91.5K is below the market average of $219.0K, reflecting a high-volume, competitive pricing strategy.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• THE ORDER OF — $24.0M across 262 shipments (47.7% of this supplier's total exports)

• RWANDA MEDICAL SUPPL — $16.5M across 180 shipments (32.7% of this supplier's total exports)

• SAI PHARMA CO LTD — $4.8M across 52 shipments (9.5% of this supplier's total exports)

• MINISTRY OF HEALTH, — $2.7M across 29 shipments (5.3% of this supplier's total exports)

• XXATRXX HEXXTHCXXE (XXY) XXD XXMPTXX PAXX — $2.4M across 26 shipments (4.8% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED operates with high shipment frequency (550 shipments) at a per-shipment value of $91.5K, indicating a broad distribution network with many smaller, regular orders.

3CIPLA LIMITED

CIPLA LIMITED is the third-largest Ritonavir exporter from India, with a market share of 6.9% and a total export value of $23.6M across 28 shipments. Their average shipment value of $841.9K is above the market average of $219.0K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CENTRAL PHARMACEUTICAL CPC1.JSC — $10.9M across 13 shipments (46.4% of this supplier's total exports)

• CENTRAL PHARMACEUTICAL CPC1.JSC — $10.1M across 12 shipments (42.7% of this supplier's total exports)

• MEDPRO PHARMACEUTICA — $2.3M across 3 shipments (9.6% of this supplier's total exports)

• TO THE ORDER OF — $193.8K across 0 shipments (0.8% of this supplier's total exports)

• CENTRAL PHARMACEUTICAL CPC1.JSC — $135.8K across 0 shipments (0.6% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $841.9K is 284% above the market average of $219.0K, consistent with large-order contracts or value-added formulations.

4EMCURE PHARMACEUTICALS LIMITED

EMCURE PHARMACEUTICALS LIMITED is the fourth-largest Ritonavir exporter from India, with a market share of 2.2% and a total export value of $7.4M across 110 shipments. Their average shipment value of $67.4K is below the market average of $219.0K, reflecting a high-volume, competitive pricing strategy.

EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• KENYA MEDICAL SUPPLIES AUTHORITY COMMERCIAL STREET INDUSTRIAL AREA — $2.5M across 37 shipments (33.8% of this supplier's total exports)

• ETHIOPIAN PHARMACEUT — $1.8M across 27 shipments (24.2% of this supplier's total exports)

• KENYA MEDICAL SUPPLIES AUTHORITY COMMERCIAL STREET INDUSTRIAL AREA — $1.2M across 17 shipments (15.8% of this supplier's total exports)

• MINISTRY OF HEALTH AND CHILD CARE — $1.0M across 15 shipments (14.1% of this supplier's total exports)

• USAID — $898.5K across 13 shipments (12.1% of this supplier's total exports)

Key Insight: EMCURE PHARMACEUTICALS LIMITED operates with high shipment frequency (110 shipments) at a per-shipment value of $67.4K, indicating a broad distribution network with many smaller, regular orders.

5EMCURE PHARMACEUTICALS LTD

EMCURE PHARMACEUTICALS LTD is the fifth-largest Ritonavir exporter from India, with a market share of 1.0% and a total export value of $3.5M across 8 shipments. Their average shipment value of $435.9K is above the market average of $219.0K, suggesting premium or bulk contract pricing.

EMCURE PHARMACEUTICALS LTD serves 5 named buyers in our database. MINISTRY OF HEALTH G is the dominant customer, accounting for 52.7% of this supplier's tracked business. Top customers include:

• MINISTRY OF HEALTH G — $1.8M across 4 shipments (52.7% of this supplier's total exports)

• KENYA MEDICAL SUPPLIES AUTHORITY COMMERCIAL STREET INDUSTRIAL AREA — $1.2M across 3 shipments (35.1% of this supplier's total exports)

• UAB LABTEKA VILKPEDE — $171.1K across 0 shipments (4.9% of this supplier's total exports)

• UNITED NATIONS OFFIC — $153.9K across 0 shipments (4.4% of this supplier's total exports)

• COSPHARM TAMPLUS DIS — $101.5K across 0 shipments (2.9% of this supplier's total exports)

Key Insight: EMCURE PHARMACEUTICALS LTD's per-shipment value of $435.9K is 99% above the market average of $219.0K, consistent with large-order contracts or value-added formulations.

6AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the fifth-largest Ritonavir exporter from India, with a market share of 0.7% and a total export value of $2.3M across 104 shipments. Their average shipment value of $21.8K is below the market average of $219.0K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO — $846.8K across 39 shipments (37.4% of this supplier's total exports)

• UNITED NATIONS OFFIC — $426.3K across 20 shipments (18.8% of this supplier's total exports)

• UNIMED SDN BHD — $336.5K across 15 shipments (14.9% of this supplier's total exports)

• UNIMED SDN BHD — $335.4K across 15 shipments (14.8% of this supplier's total exports)

• MINISTRY OF HEALTH, — $320.8K across 15 shipments (14.2% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (104 shipments) at a per-shipment value of $21.8K, indicating a broad distribution network with many smaller, regular orders.

1Belgium

Belgium ranks as the first-largest destination for Ritonavir imports from India, with a total trade value of $175.4M across 28 shipments — representing a 51.5% share of all Ritonavir exports. The average shipment value of $6.3M is above the global average of $219.0K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Ritonavir importers in Belgium: EXPEDITORS INTERNATIONAL NV is the largest buyer, accounting for 5.7% ($10.0M) of this market's total imports.

• EXPEDITORS INTERNATIONAL NV — $10.0M (5.7% of Belgium's total)

• PFIZER SER CO BV — $8.5M (4.9% of Belgium's total)

• M S TO THE ORDER OF ESSERS LSP I — $8.5M (4.9% of Belgium's total)

Key Insight: Belgium's per-shipment average of $6.3M (2760% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Ritonavir imports from India.

Primary Market

Secondary Market

2Indonesia

Indonesia ranks as the second-largest destination for Ritonavir imports from India, with a total trade value of $26.6M across 0 shipments — representing a 7.8% share of all Ritonavir exports. The average shipment value of $26.6M is above the global average of $219.0K, indicating high-value procurement contracts or branded formulations.

Key Insight: Indonesia's per-shipment average of $26.6M (12047% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Indonesia is a key market for Ritonavir imports from India.

Primary Market

Secondary Market

3Vietnam

Vietnam ranks as the third-largest destination for Ritonavir imports from India, with a total trade value of $21.3M across 4 shipments — representing a 6.3% share of all Ritonavir exports. The average shipment value of $5.3M is above the global average of $219.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Ritonavir importers in Vietnam: CENTRAL PHARMACEUTICAL CPC1. JSC is the largest buyer, accounting for 51.3% ($10.9M) of this market's total imports.

• CENTRAL PHARMACEUTICAL CPC1. JSC — $10.9M (51.3% of Vietnam's total)

• CENTRAL PHARMACEUTICAL CPC1.JSC — $10.1M (47.2% of Vietnam's total)

Key Insight: Vietnam's per-shipment average of $5.3M (2334% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Vietnam is a key market for Ritonavir imports from India.

Primary Market

Secondary Market

4Rwanda

Rwanda ranks as the fourth-largest destination for Ritonavir imports from India, with a total trade value of $16.5M across 0 shipments — representing a 4.9% share of all Ritonavir exports. The average shipment value of $16.5M is above the global average of $219.0K, indicating high-value procurement contracts or branded formulations.

Key Insight: Rwanda's per-shipment average of $16.5M (7455% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Rwanda is a key market for Ritonavir imports from India.

Primary Market

Secondary Market

5South Africa

South Africa ranks as the fifth-largest destination for Ritonavir imports from India, with a total trade value of $12.7M across 14 shipments — representing a 3.7% share of all Ritonavir exports. The average shipment value of $904.1K is above the global average of $219.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Ritonavir importers in South Africa: XXATRXX HEXXTHCXXE (XXY) XXD XXMPTXX PAXX is the largest buyer, accounting for 19.1% ($2.4M) of this market's total imports.

• XXATRXX HEXXTHCXXE (XXY) XXD XXMPTXX PAXX — $2.4M (19.1% of South Africa's total)

• VIATRIS HEALTHCARE PTY LIMITED KEMPTON PARK — $2.4M (19.1% of South Africa's total)

Key Insight: South Africa's per-shipment average of $904.1K (313% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

South Africa is a key market for Ritonavir imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ritonavir.
2.Flow Mapping: 84 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,555 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 155 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,555 Verified Shipments

84 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Ritonavir

Ritonavir

Who Supplies Ritonavir? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Ritonavir — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Ritonavir? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Ritonavir Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1HETERO LABS LIMITED

2MYLAN LABORATORIES LIMITED

3CIPLA LIMITED

4EMCURE PHARMACEUTICALS LIMITED

5EMCURE PHARMACEUTICALS LTD

6AUROBINDO PHARMA LTD

From Indian Factories to Global Pharmacies — How Ritonavir Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Ritonavir Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Belgium

2Indonesia

3Vietnam

4Rwanda

5South Africa

People Also Ask — Ritonavir Supplier & Trade Network

Ritonavir Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology